Literature DB >> 18165034

Cementless modular centroid reconstruction cup in young adults with congenital dysplasia of the hip.

Panagiotis Koulouvaris1, Kosmas Stafylas, Theodore Xenakis.   

Abstract

The anatomic abnormalities associated with the dysplastic acetabulum make total hip arthroplasty a very complex and challenging procedure. Various techniques have been reported for the reconstruction of the dysplastic acetabulum. This prospective study examined the clinical results and technical challenges associated with acetabular reconstruction using a cementless modular centroid reconstruction cup in 62 dysplastic hips. The mean follow-up period was 62 +/- 9.2 months (range, 46-84 months). No patient was lost to follow-up. There were no revisions and no radiographic signs of osteolysis. There was a significant improvement in hip pain (P < .0001), mobility (P < .0001), and walking (P < .0001) according to D'Aubigne score. Midterm results have been favorable and patients have gained high clinical function. Longer-term follow-up is registered concerning wear and loosening.

Entities:  

Mesh:

Year:  2007        PMID: 18165034     DOI: 10.1016/j.arth.2007.01.003

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  The techniques of soft tissue release and true socket reconstruction in total hip arthroplasty for patients with severe developmental dysplasia of the hip.

Authors:  Xing Wu; Shao-hua Li; Lie-ming Lou; Zheng-dong Cai
Journal:  Int Orthop       Date:  2012-07-22       Impact factor: 3.075

Review 2.  Reconstruction of the Acetabulum in Developmental Dysplasia of the Hip in total hip replacement.

Authors:  Vasileios I Sakellariou; Michael Christodoulou; Gregory Sasalos; George C Babis
Journal:  Arch Bone Jt Surg       Date:  2014-09-15

3.  Isolated polyethylene exchange versus acetabular revision for polyethylene wear.

Authors:  Camilo Restrepo; Elie Ghanem; Carrie Houssock; Mathew Austin; Javad Parvizi; William J Hozack
Journal:  Clin Orthop Relat Res       Date:  2008-10-10       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.